Skip to content
  • Home
  • What we do
  • What is leprosy?
  • Partners
  • About NLR
  • Contact
Menu
  • Home
  • What we do
  • What is leprosy?
  • Partners
  • About NLR
  • Contact

Research

  • Development and structural validation of a shortened version of the Participation Scale

  • Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination

  • Lay and peer counsellors to reduce leprosy-related stigma–lessons learnt in Cirebon, Indonesia

  • Measuring leprosy-related stigma – a pilot study to validate a toolkit of instruments

  • Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy

  • Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three-year follow-up feasibility study in Indonesia

  • The Development of a Mobile Application to Support Peripheral Health Workers to Diagnose and Treat People with Skin Diseases in Resource-Poor Settings

  • Towards a toolkit for cross-neglected tropical disease morbidity and disability assessment

  • An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++

Posts pagination

Previous 1 2
  • Home
  • What we do
  • What is leprosy?
  • Partners
  • About NLR
  • Contact
  • News articles
  • Blogs
  • Research
  • Vacancies
  • Annual reports
  • Photography

Wibautstraat 137k
1097DN Amsterdam
The Netherlands

P.O. Box 95005
1090HA Amsterdam
The Netherlands

info@nlrinternational.org +31 (0)20 59 50 500

  • Logo ANBI
  • Logo Centraal Bureau Fondsenwerving
  • Privacy
  • Cookies
  • Logo Infolep
  • Logo Infontd
  • Logo Leprosy Research Initiative
  • Logo Global Partnership for Zero Leprosy - GPZL
  • Logo Ilepfederation
  • Logo Neglected Tropical Disease NGO Network